相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Medically Induced Euthyroid Hypothyroxinemia May Extend Survival in Compassionate Need Cancer Patients: An Observational Study
Aleck Hercbergs et al.
ONCOLOGIST (2015)
Modulation of angiogenesis by thyroid hormone and hormone analogues: implications for cancer management
Shaker A. Mousa et al.
ANGIOGENESIS (2014)
T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation
Anna Perri et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis
Paul J. Davis et al.
ONCOTARGETS AND THERAPY (2014)
Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells
Keren Cohen et al.
ONCOTARGET (2014)
Small and innavative molecules as ne strategy to revert MDR
Laura Zinzi et al.
FRONTIERS IN ONCOLOGY (2014)
Cyp1B1 expression promotes angiogenesis by suppressing NF-κB activity
Tammy L. Palenski et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2013)
Thyroid hormone receptors and cancer
Won Gu Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Integrin control of the transforming growth factor-β pathway in glioblastoma
Patrick Roth et al.
BRAIN (2013)
Thyroid Hormone Regulation of miR-21 Enhances Migration and Invasion of Hepatoma
Ya-Hui Huang et al.
CANCER RESEARCH (2013)
miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF
Chun-Yan Sun et al.
CARCINOGENESIS (2013)
Thyroid hormone actions in liver cancer
Sheng-Ming Wu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone
Hung-Yun Lin et al.
FASEB JOURNAL (2013)
Interplay between αvβ3 Integrin and Nucleolin Regulates Human Endothelial and Glioma Cell Migration
Marina Koutsioumpa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer
Dhruba J. Bharali et al.
NANOMEDICINE (2013)
In Vivo Monitoring of Angiogenesis Inhibition via Down-Regulation of Mir-21 in a VEGFR2-Luc Murine Breast Cancer Model Using Bioluminescent Imaging
Dongliang Zhao et al.
PLOS ONE (2013)
Adjunctive Input to the Nuclear Thyroid Hormone Receptor from the Cell Surface Receptor for the Hormone
Paul J. Davis et al.
THYROID (2013)
OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways
Hany A. Omar et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets
Elin Hadler-Olsen et al.
TUMOR BIOLOGY (2013)
Response of Human Pancreatic Cancer Cell Xenografts to Tetraiodothyroacetic Acid Nanoparticles (Publication with Expression of Concern. See vol. 14, 2023)
Murat Yalcin et al.
HORMONES & CANCER (2013)
Small Molecule Hormone or Hormone-Like Ligands of Integrin αVβ3: Implications for Cancer Cell Behavior
Paul J. Davis et al.
HORMONES & CANCER (2013)
Integrin-αvβ3 regulates thrombopoietin-mediated maintenance of hematopoietic stem cells
Terumasa Umemoto et al.
BLOOD (2012)
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
Bryan D. White et al.
GASTROENTEROLOGY (2012)
The wnt/beta-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer
Taj D. King et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts
Shaker A. Mousa et al.
LUNG CANCER (2012)
Circulating Thyroxine, Thyroid-Stimulating Hormone, and Hypothyroid Status and the Risk of Prostate Cancer
Alison M. Mondul et al.
PLOS ONE (2012)
Vascular Hyperpermeability, Angiogenesis, and Stroma Generation
Janice A. Nagy et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Membrane Receptor for Thyroid Hormone: Physiologic and Pharmacologic Implications
Paul J. Davis et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Hypothyroidism in Patients With Renal Cell Carcinoma Blessing or Curse?
Manuela Schmidinger et al.
CANCER (2011)
Endocytosis of Resveratrol via Lipid Rafts and Activation of Downstream Signaling Pathways in Cancer Cells
Didier Colin et al.
CANCER PREVENTION RESEARCH (2011)
Radiosensitization and production of DNA double-strand breaks in U87MG brain tumor cells induced by tetraiodothyroacetic acid (tetrac)
Aleck H. Hercbergs et al.
CELL CYCLE (2011)
Maternal Thyroid Hormone before the Onset of Fetal Thyroid Function Regulates Reelin and Downstream Signaling Cascade Affecting Neocortical Neuronal Migration
Amrita Pathak et al.
CEREBRAL CORTEX (2011)
Integrin αvβ3 Promotes Vitronectin Gene Expression in Human Ovarian Cancer Cells by Implicating Rel Transcription Factors
Ute Reuning
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Thyroid Hormone Is a MAPK-Dependent Growth Factor for Human Myeloma Cells Acting via αvβ3 Integrin
Keren Cohen et al.
MOLECULAR CANCER RESEARCH (2011)
Crosstalk between Integrin αvβ3 and Estrogen Receptor-α Is Involved in Thyroid Hormone-Induced Proliferation in Human Lung Carcinoma Cells
Ran Meng et al.
PLOS ONE (2011)
Pharmacodynamic Modeling of Anti-Cancer Activity of Tetraiodothyroacetic Acid in a Perfused Cell Culture System
Hung-Yun Lin et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
The Impact of Thyroid Disease on the Regulation, Expression, and Function of ABCB1 (MDR1/P-Glycoprotein) and Consequences for the Disposition of Digoxin
O. Burk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Molecular Aspects of Thyroid Hormone Actions
Sheue-Yann Cheng et al.
ENDOCRINE REVIEWS (2010)
Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma of the Thyroid
M. Yalcin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Tetraiodothyroacetic Acid and Tetraiodothyroacetic Acid Nanoparticle Effectively Inhibit the Growth of Human Follicular Thyroid Cell Carcinoma
Murat Yalcin et al.
THYROID (2010)
Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology
Aleck H. Hercbergs et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
L-Thyroxine vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
Hung-Yun Lin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Radiosensitization of GL261 glioma cells by tetraiodothyroacetic acid (tetrac)
Aleck Hercbergs et al.
CELL CYCLE (2009)
The pro-apoptotic action of stilbene-induced COX-2 in cancer cells Convergence with the anti-apoptotic effect of thyroid hormone
Hung-Yun Lin et al.
CELL CYCLE (2009)
Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac)
Anna B. Glinskii et al.
CELL CYCLE (2009)
Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-α-positive and -negative breast cancer cells
Hung-Yun Lin et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent
Abdelhadi Rebbaa et al.
ANGIOGENESIS (2008)
Thyroid hormone receptor mediates human MDR1 gene expression -: Identification of the response region essential for gene expression
Kouichi Kurose et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines
Ruey-Nan Chen et al.
ENDOCRINOLOGY (2008)
Actin cytoskeletal organisation in osteoclasts: A model to decipher transmigration and matrix degradation
Frederic Saltel et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2008)
Effects of thyroid hormones on human breast cancer cell proliferation
Linda C. Hall et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Thyroid hormone resistance
N. K. Agrawal et al.
POSTGRADUATE MEDICAL JOURNAL (2008)
Metabolic effects of thyroid hormone derivatives
Maria Moreno et al.
THYROID (2008)
Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor
Shaker A. Mousa et al.
ANGIOGENESIS (2008)
Thyroid hormone regulates the expression and function of P-glycoprotein in Caco-2 cells
Naoki Nishio et al.
PHARMACEUTICAL RESEARCH (2008)
Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated
Hung-Yun Lin et al.
CARCINOGENESIS (2008)
被撤回的出版物: Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic (Retracted article. See vol. 195, 2023)
Hung-Yun Lin et al.
STEROIDS (2007)
Association between development of hypothyroidism and improved survival in patients with head and neck cancer
Marc Nelson et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2006)
Integrin αVβ3 contains a receptor site for resveratrol
Hung-Yun Lin et al.
FASEB JOURNAL (2006)
Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells
Faith B. Davis et al.
CANCER RESEARCH (2006)
Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated
SA Mousa et al.
ENDOCRINOLOGY (2006)
The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin
SA Mousa et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Integrin αvβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis
JJ Bergh et al.
ENDOCRINOLOGY (2005)
Thyroid hormone and breast carcinoma - Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma
M Cristofanilli et al.
CANCER (2005)
Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor
HY Tang et al.
ENDOCRINOLOGY (2004)
Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface
FB Davis et al.
CIRCULATION RESEARCH (2004)
Identification of the putative MAP kinase docking site in the thyroid hormone receptor-β1 DNA-binding domain:: Functional consequences of mutations at the docking site
HY Lin et al.
BIOCHEMISTRY (2003)
Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase
A Shih et al.
BIOCHEMISTRY (2001)
Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR
PJ Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
